Literature DB >> 23505317

Complexity of microRNA function and the role of isomiRs in lipid homeostasis.

Kasey C Vickers1, Praveen Sethupathy, Jeanette Baran-Gale, Alan T Remaley.   

Abstract

MicroRNAs (miRNAs) are key posttranscriptional regulators of biological pathways that govern lipid metabolic phenotypes. Recent advances in high-throughput small RNA sequencing technology have revealed the complex and dynamic repertoire of miRNAs. Specifically, it has been demonstrated that a single genomic locus can give rise to multiple, functionally distinct miRNA isoforms (isomiR). There are several mechanisms by which isomiRs can be generated, including processing heterogeneity and posttranscriptional modifications, such as RNA editing, exonuclease-mediated nucleotide trimming, and/or nontemplated nucleotide addition (NTA). NTAs are dominant at the 3'-end of a miRNA, are most commonly uridylation or adenlyation events, and are catalyzed by one or more of several nucleotidyl transferase enzymes. 3' NTAs can affect miRNA stability and/or activity and are physiologically regulated, whereas modifications to the 5'-ends of miRNAs likely alter miRNA targeting activity. Recent evidence also suggests that the biogenesis of specific miRNAs, or small RNAs that act as miRNAs, can occur through unconventional mechanisms that circumvent key canonical miRNA processing steps. The unveiling of miRNA diversity has significantly added to our view of the complexity of miRNA function. In this review we present the current understanding of the biological relevance of isomiRs and their potential role in regulating lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23505317      PMCID: PMC3622316          DOI: 10.1194/jlr.R034801

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  139 in total

1.  Identification of MicroRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening.

Authors:  Ross Whittaker; Patricia A Loy; Eugene Sisman; Eigo Suyama; Pedro Aza-Blanc; Randall S Ingermanson; Jeffrey H Price; Patrick M McDonough
Journal:  J Biomol Screen       Date:  2010-07-16

2.  Complexity of the microRNA repertoire revealed by next-generation sequencing.

Authors:  Lik Wee Lee; Shile Zhang; Alton Etheridge; Li Ma; Dan Martin; David Galas; Kai Wang
Journal:  RNA       Date:  2010-09-28       Impact factor: 4.942

3.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

4.  miR-122 regulates hepatic lipid metabolism and tumor suppression.

Authors:  Jessica Wen; Joshua R Friedman
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

5.  Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism.

Authors:  Michihiro Matsumoto; Seongah Han; Tadahiro Kitamura; Domenico Accili
Journal:  J Clin Invest       Date:  2006-08-10       Impact factor: 14.808

Review 6.  Functions and regulation of RNA editing by ADAR deaminases.

Authors:  Kazuko Nishikura
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

7.  Hyperlipidaemia due to carnitine palmitoyltransferase I deficiency.

Authors:  H Worthington; S E Olpin; I Blumenthal; A A M Morris
Journal:  J Inherit Metab Dis       Date:  2006-12-11       Impact factor: 4.982

Review 8.  Induction of cross-linking and silencing of Sp1 by transglutaminase during liver injury in ASH and NASH via different ER stress pathways.

Authors:  Soichi Kojima; Ting-Fang Kuo; Hideki Tatsukawa; Shigehisa Hirose
Journal:  Dig Dis       Date:  2011-04-27       Impact factor: 2.404

9.  Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.

Authors:  Katey J Rayner; Christine C Esau; Farah N Hussain; Allison L McDaniel; Stephanie M Marshall; Janine M van Gils; Tathagat D Ray; Frederick J Sheedy; Leigh Goedeke; Xueqing Liu; Oleg G Khatsenko; Vivek Kaimal; Cynthia J Lees; Carlos Fernandez-Hernando; Edward A Fisher; Ryan E Temel; Kathryn J Moore
Journal:  Nature       Date:  2011-10-19       Impact factor: 49.962

10.  Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration.

Authors:  Zheng Sun; Russell A Miller; Rajesh T Patel; Jie Chen; Ravindra Dhir; Hong Wang; Dongyan Zhang; Mark J Graham; Terry G Unterman; Gerald I Shulman; Carole Sztalryd; Michael J Bennett; Rexford S Ahima; Morris J Birnbaum; Mitchell A Lazar
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

View more
  21 in total

1.  Small RNA overcomes the challenges of therapeutic targeting of microsomal triglyceride transfer protein.

Authors:  Kasey C Vickers; Kathryn J Moore
Journal:  Circ Res       Date:  2013-11-08       Impact factor: 17.367

Review 2.  An overview of microRNAs.

Authors:  Scott M Hammond
Journal:  Adv Drug Deliv Rev       Date:  2015-05-12       Impact factor: 15.470

3.  Experimental verification of a conserved intronic microRNA located in the human TrkC gene with a cell type-dependent apoptotic function.

Authors:  Sadat Dokanehiifard; Bahram M Soltani; Sepideh Parsi; Fahimeh Hosseini; Mohammad Javan; Seyed Javad Mowla
Journal:  Cell Mol Life Sci       Date:  2015-03-14       Impact factor: 9.261

Review 4.  Lipoproteins and lipoprotein mimetics for imaging and drug delivery.

Authors:  C Shad Thaxton; Jonathan S Rink; Pratap C Naha; David P Cormode
Journal:  Adv Drug Deliv Rev       Date:  2016-04-29       Impact factor: 15.470

Review 5.  Synthetic high-density lipoprotein nanoparticles: Good things in small packages.

Authors:  Robert M Lavker; Nihal Kaplan; Kaylin M McMahon; Andrea E Calvert; Stephen E Henrich; Ummiye V Onay; Kurt Q Lu; Han Peng; C Shad Thaxton
Journal:  Ocul Surf       Date:  2021-04-21       Impact factor: 6.268

6.  Beyond the one-locus-one-miRNA paradigm: microRNA isoforms enable deeper insights into breast cancer heterogeneity.

Authors:  Aristeidis G Telonis; Phillipe Loher; Yi Jing; Eric Londin; Isidore Rigoutsos
Journal:  Nucleic Acids Res       Date:  2015-09-22       Impact factor: 16.971

Review 7.  miRNA dysregulation in cancer: towards a mechanistic understanding.

Authors:  Jayanth Kumar Palanichamy; Dinesh S Rao
Journal:  Front Genet       Date:  2014-03-18       Impact factor: 4.599

8.  Entropy-based model for miRNA isoform analysis.

Authors:  Shengqin Wang; Jing Tu; Lei Wang; Zuhong Lu
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

9.  Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis Programs.

Authors:  Sara R Selitsky; Timothy A Dinh; Cynthia L Toth; C Lisa Kurtz; Masao Honda; Benjamin R Struck; Shuichi Kaneko; Kasey C Vickers; Stanley M Lemon; Praveen Sethupathy
Journal:  mBio       Date:  2015-12-08       Impact factor: 7.867

10.  DeAnnIso: a tool for online detection and annotation of isomiRs from small RNA sequencing data.

Authors:  Yuanwei Zhang; Qiguang Zang; Huan Zhang; Rongjun Ban; Yifan Yang; Furhan Iqbal; Ao Li; Qinghua Shi
Journal:  Nucleic Acids Res       Date:  2016-05-13       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.